Literature DB >> 21212851

Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis).

Mary Elizabeth Hartnett1.   

Abstract

PURPOSE: To study vascular endothelial growth factor (VEGF) regulation in the development of intravitreous neovascularization and peripheral avascular retina in peripheral severe retinopathy of prematurity (ROP).
METHODS: The rat 50/10 model of ROP mimics zone II, stage 3 severe ROP and recreates fluctuations in transcutaneous oxygen levels in preterm infants. On postnatal (p) day ages p0, p8, p11-p14, and p18, retinas from the model or room-air (RA) age-matched pups were analyzed for mRNA of VEGF splice variants and receptors using real-time polymerase chain reaction or VEGF protein using enzyme-linked immunosorbent assay.
RESULTS: On p14, when retinas were only 70% vascularized in the model but fully vascularized in RA, VEGF₁₆₄ expression was threefold greater in the model compared to RA. On p18, intravitreous neovascularization was associated with a 5-fold increase in VEGF₁₆₄ mRNA in the model compared to RA. By analysis of variance, VEGF₁₆₄ and VEGFR2 mRNAs were up-regulated in association with increasing developmental age (P<.0001 for both comparisons) or exposure to the model compared to RA (P<.0001 and P=.0247, respectively), whereas increasing developmental age was associated only with up-regulated VEGF₁₂₀ (P=.0006), VEGF₁₈₈ (P=.0256), and VEGFR1 (P<.0001) mRNAs. VEGF protein increased significantly in the model and on p14 and p18 compared to RA (P<.0001).
CONCLUSIONS: The model mimics contemporary severe ROP in the United States unlike other models of oxygen-induced retinopathy. Compared to RA retinas, VEGF significantly increased in association with avascular retina and intravitreous neovascularization. A hypothesis is proposed that VEGF up-regulation plays a role in the development of both important features.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21212851      PMCID: PMC3016082     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  150 in total

1.  Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity.

Authors:  M R Niesman; K A Johnson; J S Penn
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

2.  Direct observation of the effect of oxygen on developing vessels: preliminary report.

Authors:  N ASHTON; C COOK
Journal:  Br J Ophthalmol       Date:  1954-07       Impact factor: 4.638

3.  Specific involvement of SRC family kinase activation in the pathogenesis of retinal neovascularization.

Authors:  Xiang Q Werdich; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-11       Impact factor: 4.799

Review 4.  The effect of oxygen on immature retinal vessels.

Authors:  A Patz
Journal:  Invest Ophthalmol       Date:  1965-12

Review 5.  Vascular endothelial growth factors and angiogenesis in eye disease.

Authors:  A N Witmer; G F J M Vrensen; C J F Van Noorden; R O Schlingemann
Journal:  Prog Retin Eye Res       Date:  2003-01       Impact factor: 21.198

6.  Differential expression of VEGF isoforms in mouse during development and in the adult.

Authors:  Y S Ng; R Rohan; M E Sunday; D E Demello; P A D'Amore
Journal:  Dev Dyn       Date:  2001-02       Impact factor: 3.780

7.  Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Authors:  Kazuaki Nishijima; Yin-Shan Ng; Lichun Zhong; John Bradley; William Schubert; Nobuo Jo; Jo Akita; Steven J Samuelsson; Gregory S Robinson; Anthony P Adamis; David T Shima
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

8.  VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2.

Authors:  Tomohiko Usui; Susumu Ishida; Kenji Yamashiro; Yuichi Kaji; Vasiliki Poulaki; Johnny Moore; Tara Moore; Shiro Amano; Yoshitaka Horikawa; Darlene Dartt; Matthew Golding; David T Shima; Anthony P Adamis
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-02       Impact factor: 4.799

9.  Genetic polymorphisms and retinopathy of prematurity.

Authors:  Richard W I Cooke; Jo A Drury; Roger Mountford; David Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  24 in total

Review 1.  Advances in understanding and management of retinopathy of prematurity.

Authors:  Mary Elizabeth Hartnett
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

Review 2.  Effects of oxygen on the development and severity of retinopathy of prematurity.

Authors:  M Elizabeth Hartnett; Robert H Lane
Journal:  J AAPOS       Date:  2013-06       Impact factor: 1.220

Review 3.  Pathophysiology and mechanisms of severe retinopathy of prematurity.

Authors:  M Elizabeth Hartnett
Journal:  Ophthalmology       Date:  2014-10-14       Impact factor: 12.079

4.  Spectral-domain optical coherence tomographic assessment of severity of cystoid macular edema in retinopathy of prematurity.

Authors:  Ramiro S Maldonado; Rachelle O'Connell; Simon B Ascher; Neeru Sarin; Sharon F Freedman; David K Wallace; Stephanie J Chiu; Sina Farsiu; Michael Cotten; Cynthia A Toth
Journal:  Arch Ophthalmol       Date:  2012-05

5.  17β-estradiol ameliorates oxygen-induced retinopathy in the early hyperoxic phase.

Authors:  Hongbing Zhang; Xiaodong Wang; Kun Xu; Yao Wang; Yani Wang; Xianning Liu; Xianjiao Zhang; Liang Wang; Xiaogang Li
Journal:  Biochem Biophys Res Commun       Date:  2015-01-22       Impact factor: 3.575

6.  Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity.

Authors:  Haibo Wang; Zhihong Yang; Yanchao Jiang; John Flannery; Scott Hammond; Tal Kafri; Sai Karthik Vemuri; Bryan Jones; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-04       Impact factor: 4.799

7.  17-Alpha-estradiol ameliorating oxygen-induced retinopathy in a murine model.

Authors:  Hong-Bing Zhang; Nai-Xue Sun; Hou-Cheng Liang; Xiang-Hua Xiao; Xian-Ning Liu; Ya-Ni Wang
Journal:  Jpn J Ophthalmol       Date:  2012-05-15       Impact factor: 2.447

8.  Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity.

Authors:  Haibo Wang; George W Smith; Zhihong Yang; Yanchao Jiang; Manabu McCloskey; Kenneth Greenberg; Pete Geisen; William D Culp; John Flannery; Tal Kafri; Scott Hammond; M Elizabeth Hartnett
Journal:  Am J Pathol       Date:  2013-09       Impact factor: 4.307

Review 9.  Arginase in retinopathy.

Authors:  S Priya Narayanan; Modesto Rojas; Jutamas Suwanpradid; Haroldo A Toque; R William Caldwell; Ruth B Caldwell
Journal:  Prog Retin Eye Res       Date:  2013-07-03       Impact factor: 21.198

10.  Treatment with polyamine oxidase inhibitor reduces microglial activation and limits vascular injury in ischemic retinopathy.

Authors:  C Patel; Z Xu; E Shosha; J Xing; R Lucas; R W Caldwell; R B Caldwell; S P Narayanan
Journal:  Biochim Biophys Acta       Date:  2016-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.